You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Medications Research Articles
Popular Medications Research Articles
Highly Recommended Medications Research Articles
Send a link to this page to your friends and colleagues.
Aspirin has been shown to help prevent heart disease among people with diabetes. The American Diabetes Association (ADA) has recommended the over-the-counter pain reliever to diabetic adults who have cardiovascular disease or are at risk for it.
However, that has not seemed to make a difference, according to researchers at the Centers for Disease Control in Atlanta.
In a report published in the February issue of Diabetes Care, the researchers revealed the results of a study showing that only one in five diabetes patients with heart disease or those at risk take aspirin on a regular basis.
In the study, researchers examined data from 1,503 participants in the Third National Health and Nutrition Examination Survey (NHANES III) to track aspirin use among the diabetic public.
In a March 2 interview with Reuters Health, lead researcher Deborah B. Rolka said, “People with diabetes are known to be at much greater risk than people without diabetes of developing heart disease and dying from it, so it is somewhat surprising that regular aspirin use was not more common among people with diabetes.”
But researchers noted that the survey was taken from 1988 to 1994, prior to recent efforts to educate doctors and patients about the benefits of taking aspirin. Rolka noted that future studies may reveal that aspirin intake will have increased since 1994.
Currently, the ADA recommends taking 81 to 325 mg of enteric-coated aspirin per day.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.